de.advfn.com/p.php?pid=nmona&article=80026244
Werbung
| Strategie | Hebel | |||
| Steigender DAX-Kurs | 5,00 | 9,99 | 15,00 | |
| Fallender DAX-Kurs | 5,00 | 10,02 | 14,98 | |
|
Hübscher Chart (kürzlich Golden Cross) und News stehen an - Handel drüben ausgesetzt, auf L&S grad eben noch ein paar Stücke geschossen.
Schaun wir mal...
https://twitter.com/search?q=%24IPA.V&src=cashtag_click&f=live
"EVQLV is working on the advancement with Immunoprecise Antibodies (IPA), a bioscience research company concentrating on discovering therapeutic antibodies.
The collaboration “will accelerate the effort to develop therapeutic candidates against COVID-19,” according to the news report. “EVQLV will identify and screen hundreds of millions of potential antibody treatments in only a few days—far beyond the capacity of any laboratory.”
With the algorithmic screening complete, IPA will produce and test the most promising antibody candidates..."
https://www.aiin.healthcare/topics/...ce-covid-19-treatment-discovery
Werbung
| Strategie | Hebel | |||
| Steigender DAX-Kurs | 5,00 | 9,99 | 15,00 | |
| Fallender DAX-Kurs | 5,00 | 10,02 | 14,98 | |
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 2 | ImmunoPrecise Antibodies Announces an Unprecedente | AWSX | calimera | 29.03.20 17:39 |
